We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Xceleron Expands Agreement with GlaxoSmithKline

News   Aug 21, 2009

 
Xceleron Expands Agreement with GlaxoSmithKline
 
 
 

RELATED ARTICLES

Ovarian Cancer Biomarker Can Predict Patient Therapy Response

News

Researchers have identified an independent prognostic factor - cancer/testis antigen 45 (CT45) - and have begun to elucidate it's actions. CT45 is associated with extended disease-free survival for women with advanced ovarian cancer.

READ MORE

Imaging Pesticides in Insects could Improve Safety

News

Researchers develop a new way of looking at insect bodies to answer questions about the effectiveness of pesticides and guide development of more specific alternatives.

READ MORE

Obesity & Vitamin D Deficiency May Indicate Greater Breast Cancer Risk

News

New study demonstrates that postmenopausal women have an increased risk of vitamin D deficiency at the time of breast cancer diagnosis, associated with a higher rate of obesity.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE